Medtronic today said it has received CE mark approval for its radial artery access portfolio.
The radial artery access devices include the Rist 079 radial access guide catheter and the Rist radial access selective catheter.
Medtronic designed the Rist 079 guide catheter to access the neuro vasculature through the radial artery instead of through the transfemoral artery. The device is cleared by the FDA. It is indicated for the introduction of interventional devices into the peripheral, coronary and neuro vasculature.
“With excellent navigability, this first-of-its-kind device will allow clinicians to reach distal locations while still achieving excellent stability to the system,” Alejandro Tomasello, head of interventional neuroradiology at Vall d’Hebron Hospital in Barcelona, Spain, said in a news release. “The radial artery-access portfolio works well in tandem with Phenom Plus, Phenom 021 microcatheter for stent deployment or Phenom 027 microcatheter for flow diverter deployment, which is a fantastic set up for Pipeline VANTAGE embolization device with shield technology treatments.”
The Rist radial access selective catheter is indicated for the introduction of interventional devices into the peripheral, coronary and neuro vasculature, according to the company. It can introduce diagnostic agents into the neuro vasculature but not the coronary and peripheral arteries.
“We are committed to exploring ways to improve outcomes through complication reduction, reducing the cost of care and improving the overall patient experience. We believe radial access is a meaningful addition to the clinical armamentarium,” Dan Volz, president of Medtronic’s neurovasacular therapies business, said. “The CE Mark approval of the Rist radial access portfolio emphasizes our focus on driving innovation that gives clinicians who perform neurovascular procedures the broadest product portfolio so they can customize their care based on a patient’s condition and anatomy.”
Medtronic acquired Rist Neurovascular and its Rist 079 Radial Access Guide catheter and the Rist radial access selective catheter in August 2020 for an undisclosed amount. The acquisition expanded Medtronic’s neuromuscular portfolio to serve patients that require interventional neurovascular therapy.